This is an outdated version published on 22-02-2024. Read the most recent version.

Angelica glauca oil exhibits antidepressant-like effect in experimental animals: An in silico, ADMET and in vivo investigation

Authors

DOI:

https://doi.org/10.14719/tcb.2868

Keywords:

Angelica glauca, Antidepressant, ADMET, Molecular docking, Behavioral models, Histopathology

Abstract

Angelica glauca is an aromatic plant of the Apiaceae family. Traditionally A. glauca is used to cure several diseases including anxiety and depression. The present investigation is focused on studying the in silico and in-vivo antidepressant potential of A. glauca essential oil (AGEO). The GC-MS analysis was performed on A. glauca root oil to confirm the genuineness of the drug. Compounds viz. alpha phellandrene, limonene, and z-ligustilide obtained through GC-MS analysis were screened for Monoamine oxidase from Aspergillus niger (MAO-N) (PDB: 2vvl) binding through molecular docking studies by using autoDock/Mcule tool. Prediction of ADME and physicochemical properties of above-detected compounds was done by using preADMET tool version 2.0. The antidepressant activity was investigated by the forced swimming method and tail suspension method. The docking studies exhibits that limonene has a maximum affinity for MAO-N, followed by alpha phellandrene and z-ligustilide. It has been observed that upon oral administration of A. glauca oil (250 & 500 µl/kg b.w.) and reference drug selegiline at the dose of (0.2 mg/kg) shows significant (p<0.01) reduction in immobility in rats in both the behavioral models. All the results were compared with the control group and justified by histopathological analysis of the brain. The data obtained from the study suggests the antidepressant-like action of A. glauca root oil and its phytocompounds in the behavioral models of FST and TST in a dose-dependent manner.

Downloads

Download data is not yet available.

References

Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471-481. https://doi:10.1017/S0033291712001511

Nemeroff CB, Owens MJ. Treatment of mood disorders. Nat Neurosci. 2002;5 Suppl:1068-1070. https://doi:10.1038/nn943

Chisholm D, Sweeny K, Sheehan P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3(5):415-424. https://doi:10.1016/S2215-0366(16)30024-4

Björkholm C, Monteggia LM. BDNF - a key transducer of antidepressant effects. Neuropharmacol. 2016;102:72-79. https://doi:10.1016/j.neuropharm.2015.10.034

Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7(2):137-151. https://doi:10.1038/nrn1846

Kaul PN, Mallavarapu GR, Chamoli RP. The essential oil composition of Angelica glauca roots. Planta Med. 1996;62(1):80-81. https://doi:10.1055/s-2006-957812

Agnihotri VK, Thappa RK, Meena B, et al. Essential oil composition of aerial parts of Angelica glauca growing wild in North-West Himalaya (India). Phytochemistry. 2004;65(16):2411-2413. https://doi:10.1016/j.phytochem.2004.07.004

Irshad M, Aziz S, Rehman H, Hussain H. GC-MS analysis and antifungal activity of essential oil of Angelica glauca, Plectranthus rugosus and Valeriana wallichii. J Essent Oil Bear Plants. 2012;15:15–21.

Irshad M, Rehman HU, Shahid M, Aziz S, Ghous T. Antioxidant, antimicrobial and phytotoxic activities of essential oil of Angelica glauca. Asian J Chem. 2011;23:1947–51.

Pillai SG, Yadav Y, Sharma K. A Review on an endangered himalayan medicinal aromatic plant - Choraka (Angelica glauca Edgew). Int Ayur Med J. 2020; Available from: http://www.iamj.in/posts/images/upload/4508_4515.pdf

Sharma S, Rasal VP, Patil PA, Joshi RK. Effect of Angelica glauca essential oil on allergic airway changes induced by histamine and ovalbumin in experimental animals. Indian J Pharmacol. 2017;49(1):55-59. https://doi:10.4103/0253-7613.201019

Mannan A, Abir AB, Rahman R. Antidepressant-like effects of methanolic extract of Bacopa monniera in mice. BMC Complement Altern Med. 2015; 15:337 https://doi.org/10.1186/s12906-015-0866-2

Long Y, Li D, Yu S, et al. Medicine-food herb: Angelica sinensis, a potential therapeutic hope for Alzheimer's disease and related complications. Food & Function. 2022;13(17):8783-8803. https://doi:10.1039/d2fo01287a.

Ma JC, Zhang HL, Huang HP, et al. Antidepressant-like effects of Z-ligustilide on chronic unpredictable mild stress-induced depression in rats. Exp Ther Med. 2021;22(1):677. https://doi:10.3892/etm.2021.10109

Jang DP, Lee SH, Lee SY, Park CW, Cho ZH, Kim YB. Neural responses of rats in the forced swimming test: [F-18] FDG micro PET study. Behav Brain Res. 2009;203(1):43-47. https://doi:10.1016/j.bbr.2009.04.020

Vazquez-Matias DA, de Vries EFJ, Dierckx RAJO, et al. PET imaging of animal models with depressive-like phenotypes. Eur J Nucl Med Mol Imaging. 2023; 50, 1564–1584 https://doi.org/10.1007/s00259-022-06073-4

Boiangiu RS, Bagci E, Dumitru G, Hritcu L, Todirascu-Ciornea E. Angelica purpurascens (Avé-Lall.) Gilli. Essential oil improved brain function via cholinergic modulation and antioxidant effects in the Scopolamine-induced Zebrafish (Danio rerio) model. Plants (Basel). 2022;11(8):1096. https://doi:10.3390/plants11081096

Liu Y, Li Y, Xie J. Traditional chinese medicine strategy for treating major depressive disorder based on a famous formulation-Baweixiaoyaosan. An. Acad. Bras. Cienc. 2023; 95(suppl 1): e20220676. https://doi:10.1590/0001-3765202320220676.

Winiarska-Mieczan A, Kwiecie? M, Jachimowicz-Rogowska K, Donaldson J, Tomaszewska E, Baranowska-Wójcik E. Anti-Inflammatory, Antioxidant, and Neuroprotective effects of polyphenols-polyphenols as an element of diet therapy in depressive disorders. Int J Mol Sci. 2023;24(3):2258. https://doi:10.3390/ijms24032258

Hassan SSU, Samanta S, Dash R, et al. The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress. Front Pharmacol. 2022;13:1015835. https://doi:10.3389/fphar.2022.1015835

Downloads

Published

01-10-2023 — Updated on 22-02-2024

Versions

Issue

Section

Research Articles